secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED GUARDIAN INC (UG)
CIK:        0000101295
Form:       8-K
Filed at:   2024-11-08T23:59:59+00:00
Accession:  0001171843-24-006160
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United-Guardian Q3 net income up to $0.19/share; nine-month sales +17%
----------------------------------------------------------------------

- Nine-month 2024 sales $9.7M (+17% YoY); net income $2.7M ($0.60/share) vs $1.8M ($0.40/share) in 2023.
- Q3 sales steady at $3.06M; net income $865K ($0.19/share) up from $627K ($0.14/share).
- Cosmetic ingredient sales surged 68% in nine months, driven by largest distributor.
- Medical lubricant sales +4% over nine months; pharmaceutical sales -11% due to Renacidin supply disruption.
- President expects continued recovery from Renacidin supply shutdown.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/101295/000117184324006160/0001171843-24-006160-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/101295/000117184324006160/f8k_110724.htm
  HTML page:      https://secwatch.observer/filing/0001171843-24-006160

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer